Susquehanna International Group’s Ambrx Biopharma Inc AMAM Stock Holding History

Susquehanna International Group’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-70,200	Closed	-$1,000K	–	13754
2023 Q4	$1,000K	Buy	70,200 +10,300	+17%	+$117K	﹤0.01%	6995
2023 Q3	$689K	Buy	59,900 +31,700	+112%	+$432K	﹤0.01%	7483
2023 Q2	$464K	Sell	28,200 -85,800	-75%	-$1.08M	﹤0.01%	8495
2023 Q1	$1.02M	Buy	+114,000	New	+$573K	﹤0.01%	6771

Susquehanna International Group's AMAM Position: Q1 2024 in Review

Susquehanna International Group sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 49,203 shares — an estimated $701K sold.

Susquehanna International Group first reported a position in AMAM in Q3 2022 and held it in 5 quarters. The position peaked at $844K in Q2 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Susquehanna International Group reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Susquehanna International Group sold 49,203 Ambrx Biopharma Inc shares in Q1 2024, an estimated $701K.
Susquehanna International Group first reported a position in Ambrx Biopharma Inc in Q3 2022 and held it in 5 quarters.
Susquehanna International Group's Ambrx Biopharma Inc position peaked at $844K in Q2 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.